Katrin Deinhardt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Katrin Deinhardt has a total of 250 co-authors. Here are the top co-authors by number of shared publications:
- Moses V. Chao
Skirball Institute for Biomolecular Medicine, New York University School of Medicine, New York, NY 10016, USA
12 shared publications - Mariana Vargas-Caballero
School of Biological Sciences, University of Southampton
9 shared publications - Giampietro Schiavo
UCL Queen Square Motor Neuron Disease Centre and Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK
8 shared publications - Aleksandra P. Pitera
MRC Laboratory of Molecular Biology 1 , Cambridge, UK
6 shared publications - Thomas A. Neubert
New York University Grossman School of Medicine
6 shared publications Mariana Vargas-Caballero
School of Biological Sciences, University of Southampton, Southampton, United Kingdom
5 shared publications
Latest Publications
- Open Access
Sensory and developmental phenotyping of C. elegans parses autism associated genes into behavioural classifications
A large subset of ASD associated genes, almost 50% of the highest confidence risk genes listed on the Simons Foundation Autism Research Institute database, are epigenetic modifiers. This suggests that the organization of sensory biology and its coupling to underlying genetic control are an important element underpinning this discord. Furthermore, sensory processing changes in individuals with autism spectrum disorder (ASD) has been a growing area of study in recent years. C. elegans have robust readouts for both developmental and sensory biology allowing these signatures of ASD to be systematically modelled. 52 epigenetic modifiers (65 strains) were selected for study in C. elegans based on gene function, presence of orthologues in C. elegans and the availability of viable putative null strains. This highlighted significant changes to reproduction, gross development and sensory processing across the range of epigenetic modifiers. Each strain was filtered against selective criteria for significant sensory and developmental phenotypes allowing for selective phenotypic profiles to emerge. These were three primary groups, those with sensory perturbations but unaffected gross development (6), developmentally affected genes with intact sensory function (10) and finally genes with impaired gross development and sensory function (11). Thus, this study provides a link between sensory and developmental outcomes in ASD associated mutant strains and suggests that more regular sensory testing should be performed in human cohorts to further refine sub-categorisation of ASD cohorts.
Open AccessSensory and developmental phenotyping of C. elegans parses autism associated genes into behavioural classifications
A large subset of ASD associated genes, almost 50% of the highest confidence risk genes listed on the Simons Foundation Autism Research Institute database, are epigenetic modifiers. This suggests that the organization of sensory biology and its coupling to underlying genetic control are an important element underpinning this discord. Furthermore, sensory processing changes in individuals with autism spectrum disorder (ASD) has been a growing area of study in recent years. C. elegans have robust readouts for both developmental and sensory biology allowing these signatures of ASD to be systematically modelled. 52 epigenetic modifiers (65 strains) were selected for study in C. elegans based on gene function, presence of orthologues in C. elegans and the availability of viable putative null strains. This highlighted significant changes to reproduction, gross development and sensory processing across the range of epigenetic modifiers. Each strain was filtered against selective criteria for significant sensory and developmental phenotypes allowing for selective phenotypic profiles to emerge. These were three primary groups, those with sensory perturbations but unaffected gross development (6), developmentally affected genes with intact sensory function (10) and finally genes with impaired gross development and sensory function (11). Thus, this study provides a link between sensory and developmental outcomes in ASD associated mutant strains and suggests that more regular sensory testing should be performed in human cohorts to further refine sub-categorisation of ASD cohorts.
- Open Access
- 4 November 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (12) , 110882
Cellular and functional insights into FIH-mediated hydroxylation of TRPA1
- 4 November 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (12) , 110882
Open AccessCellular and functional insights into FIH-mediated hydroxylation of TRPA1
- Open Access
- 1 October 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 1020
Single Nucleotide Polymorphisms in ANK3 and Psychiatric Risk: A Meta-Analysis, Systematic Review, and Quantitative Trait Locus Insights
Background Ankyrin 3 (Ankyrin G), encoded by the ANK3 gene, is a membrane-associated scaffold protein critical for neuronal signaling and highly enriched in axonal initial segments and nodes of Ranvier. ANK3 variants have been implicated in several neuropsychiatric disorders. Objectives To identify single nucleotide polymorphisms (SNPs) in ANK3 associated with psychiatric disorders, assess population-specific significance, determine variant locations, and explore regulatory effects through quantitative trait locus (QTL) analysis. Methods A meta-analysis and systematic literature review were conducted to identify disease-associated SNPs in ANK3. QTL analyses were performed using datasets from the eQTL Catalogue and GTEx v10 to evaluate regulatory effects in brain tissues. Results Meta-analysis identified significant associations between ANK3 SNPs and psychiatric disorders. In bipolar disorder, rs10994336 (OR = 1.28, P = 1.04×10 −4 ) was significant in European+North American populations; rs9804190 was protective in Europeans (OR = 0.88, P = 0.020); and rs1938526 was significant in both European+North American (OR = 1.32, P = 7.26×10 −12 ) and Asian populations (OR = 1.08, P = 4.68×10 −12 ), with an overall effect (OR = 1.17, P = 0.003). In schizophrenia, rs10761482 showed opposite effects: protective in Chinese (OR = 0.74, P = 0.002) and risk-associated in Iranian cohorts (OR = 1.57, P = 0.025). rs10994359 was protective in major depressive disorder in Asians (OR = 0.69, P = 0.016), and three SNPs reduced PTSD risk (OR = 0.48, P = 0.045). All significant variants were intronic. QTL analyses showed rs10761482 increased ANK3 expression in neocortex (P = 0.001) and neurons (P = 0.038); three PTSD SNPs showed robust cerebellar splicing effects (FDR = 0.010); and apaQTLs indicated modest 3′-UTR effects in putamen. Conclusion Multiple intronic ANK3 SNPs are significantly associated with psychiatric disorders and display tissue-specific regulatory effects. Integrating QTL data provides insights into their potential functional roles in neuropsychiatric pathogenesis.
- 1 October 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 1020
Open AccessSingle Nucleotide Polymorphisms in ANK3 and Psychiatric Risk: A Meta-Analysis, Systematic Review, and Quantitative Trait Locus Insights
Background Ankyrin 3 (Ankyrin G), encoded by the ANK3 gene, is a membrane-associated scaffold protein critical for neuronal signaling and highly enriched in axonal initial segments and nodes of Ranvier. ANK3 variants have been implicated in several neuropsychiatric disorders. Objectives To identify single nucleotide polymorphisms (SNPs) in ANK3 associated with psychiatric disorders, assess population-specific significance, determine variant locations, and explore regulatory effects through quantitative trait locus (QTL) analysis. Methods A meta-analysis and systematic literature review were conducted to identify disease-associated SNPs in ANK3. QTL analyses were performed using datasets from the eQTL Catalogue and GTEx v10 to evaluate regulatory effects in brain tissues. Results Meta-analysis identified significant associations between ANK3 SNPs and psychiatric disorders. In bipolar disorder, rs10994336 (OR = 1.28, P = 1.04×10 −4 ) was significant in European+North American populations; rs9804190 was protective in Europeans (OR = 0.88, P = 0.020); and rs1938526 was significant in both European+North American (OR = 1.32, P = 7.26×10 −12 ) and Asian populations (OR = 1.08, P = 4.68×10 −12 ), with an overall effect (OR = 1.17, P = 0.003). In schizophrenia, rs10761482 showed opposite effects: protective in Chinese (OR = 0.74, P = 0.002) and risk-associated in Iranian cohorts (OR = 1.57, P = 0.025). rs10994359 was protective in major depressive disorder in Asians (OR = 0.69, P = 0.016), and three SNPs reduced PTSD risk (OR = 0.48, P = 0.045). All significant variants were intronic. QTL analyses showed rs10761482 increased ANK3 expression in neocortex (P = 0.001) and neurons (P = 0.038); three PTSD SNPs showed robust cerebellar splicing effects (FDR = 0.010); and apaQTLs indicated modest 3′-UTR effects in putamen. Conclusion Multiple intronic ANK3 SNPs are significantly associated with psychiatric disorders and display tissue-specific regulatory effects. Integrating QTL data provides insights into their potential functional roles in neuropsychiatric pathogenesis.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S13)
Alternative splicing and characterisation of the tauopathy‐induced gene Growth Arrest DNA Damage Induced 45 alpha
Background: The Gadd45 family are a set of 3 genes classically induced by DNA damage. They are also induced by wider stresses such as axonal injury, ischemia and degenerative diseases like ALS. Increased Gadd45 protein staining is observed in AD brains, however their association with pathogenic tau is unknown. The Gadd45 genes undergo alternative splicing to generate 8 functionally distinct proteins, whose significance in neuronal systems are poorly understood. We aim to investigate if the Gadd45 family are upregulated in tauopathies and whether this is accompanied by changes to mRNA splicing of these genes, with a view to understand whether these differentially affect cell health.Method: Transgenic mice (rTg4510) over‐expressing and FTD‐associated mutant tau (TauP301L) were used to investigate tau‐associated upregulation of the Gadd45 genes. Subsequently, we analyse which splice variants are present in primary cortical neurons and express plasmid constructs of these variants to investigate their sub‐cellular localisation and function, using apoptotic cell death as a read‐out.Result: Gadd45α, but not β or γ members of the same family, is upregulated in response to pathological tau. Untreated cortical neurones express a single isoform of the Gadd45α gene, however upon cellular stress 2 additional isoforms are induced. The identified variants show distinct sub‐cellular distribution, including changes to nuclear localisation and the development of punctate staining. Furthermore, these differentially affect apoptosis.Conclusion: Gadd45α is selectively upregulated by tau pathology. The gene undergoes alternative splicing in murine neurones in response to cellular stress, and these variants show evidence for distinct functions. We will next investigate the association of these variants with pathological tau.We thank the Alzheimer’s Society for funding this work.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S13)
Open AccessAlternative splicing and characterisation of the tauopathy‐induced gene Growth Arrest DNA Damage Induced 45 alpha
Background: The Gadd45 family are a set of 3 genes classically induced by DNA damage. They are also induced by wider stresses such as axonal injury, ischemia and degenerative diseases like ALS. Increased Gadd45 protein staining is observed in AD brains, however their association with pathogenic tau is unknown. The Gadd45 genes undergo alternative splicing to generate 8 functionally distinct proteins, whose significance in neuronal systems are poorly understood. We aim to investigate if the Gadd45 family are upregulated in tauopathies and whether this is accompanied by changes to mRNA splicing of these genes, with a view to understand whether these differentially affect cell health.Method: Transgenic mice (rTg4510) over‐expressing and FTD‐associated mutant tau (TauP301L) were used to investigate tau‐associated upregulation of the Gadd45 genes. Subsequently, we analyse which splice variants are present in primary cortical neurons and express plasmid constructs of these variants to investigate their sub‐cellular localisation and function, using apoptotic cell death as a read‐out.Result: Gadd45α, but not β or γ members of the same family, is upregulated in response to pathological tau. Untreated cortical neurones express a single isoform of the Gadd45α gene, however upon cellular stress 2 additional isoforms are induced. The identified variants show distinct sub‐cellular distribution, including changes to nuclear localisation and the development of punctate staining. Furthermore, these differentially affect apoptosis.Conclusion: Gadd45α is selectively upregulated by tau pathology. The gene undergoes alternative splicing in murine neurones in response to cellular stress, and these variants show evidence for distinct functions. We will next investigate the association of these variants with pathological tau.We thank the Alzheimer’s Society for funding this work.
- Open Access
- 13 September 2023
- Published by Wiley in Journal of Neurochemistry
- Vol. 167 (1) , 90-103
Functional effects of haemoglobin can be rescued by haptoglobin in an in vitro model of subarachnoid haemorrhage
During subarachnoid haemorrhage, a blood clot forms in the subarachnoid space releasing extracellular haemoglobin (Hb), which causes oxidative damage and cell death in surrounding tissues. High rates of disability and cognitive decline in SAH survivors are attributed to loss of neurons and functional connections during secondary brain injury. Haptoglobin sequesters Hb for clearance, but this scavenging system is overwhelmed after a haemorrhage. Whilst exogenous haptoglobin application can attenuate cytotoxicity of Hb in vitro and in vivo, the functional effects of sub‐lethal Hb concentrations on surviving neurons and whether cellular function can be protected with haptoglobin treatment remain unclear. Here we use cultured neurons to investigate neuronal health and function across a range of Hb concentrations to establish the thresholds for cellular damage and investigate synaptic function. Hb impairs ATP concentrations and cytoskeletal structure. At clinically relevant but sub‐lethal Hb concentrations, we find that synaptic AMPAR‐driven currents are reduced, accompanied by a reduction in GluA1 subunit expression. Haptoglobin co‐application can prevent these deficits by scavenging free Hb to reduce it to sub‐threshold concentrations and does not need to be present at stoichiometric amounts to achieve efficacy. Haptoglobin itself does not impair measures of neuronal health and function at any concentration tested. Our data highlight a role for Hb in modifying synaptic function in surviving neurons, which may link to impaired cognition or plasticity after SAH and support the development of haptoglobin as a therapy for subarachnoid haemorrhage. image
- 13 September 2023
- Published by Wiley in Journal of Neurochemistry
- Vol. 167 (1) , 90-103
Open AccessFunctional effects of haemoglobin can be rescued by haptoglobin in an in vitro model of subarachnoid haemorrhage
During subarachnoid haemorrhage, a blood clot forms in the subarachnoid space releasing extracellular haemoglobin (Hb), which causes oxidative damage and cell death in surrounding tissues. High rates of disability and cognitive decline in SAH survivors are attributed to loss of neurons and functional connections during secondary brain injury. Haptoglobin sequesters Hb for clearance, but this scavenging system is overwhelmed after a haemorrhage. Whilst exogenous haptoglobin application can attenuate cytotoxicity of Hb in vitro and in vivo, the functional effects of sub‐lethal Hb concentrations on surviving neurons and whether cellular function can be protected with haptoglobin treatment remain unclear. Here we use cultured neurons to investigate neuronal health and function across a range of Hb concentrations to establish the thresholds for cellular damage and investigate synaptic function. Hb impairs ATP concentrations and cytoskeletal structure. At clinically relevant but sub‐lethal Hb concentrations, we find that synaptic AMPAR‐driven currents are reduced, accompanied by a reduction in GluA1 subunit expression. Haptoglobin co‐application can prevent these deficits by scavenging free Hb to reduce it to sub‐threshold concentrations and does not need to be present at stoichiometric amounts to achieve efficacy. Haptoglobin itself does not impair measures of neuronal health and function at any concentration tested. Our data highlight a role for Hb in modifying synaptic function in surviving neurons, which may link to impaired cognition or plasticity after SAH and support the development of haptoglobin as a therapy for subarachnoid haemorrhage. image
- Open Access
- 5 June 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1196007
A luminescence-based reporter to study tau secretion reveals overlapping mechanisms for the release of healthy and pathological tau
In Alzheimer’s disease, tau pathology is thought to spread via a prion-like manner along connected neuronal networks. For this to occur, the usually cytosolic tau protein must be secreted via an unconventional mechanism prior to uptake into the connected neuron. While secretion of healthy and pathological tau has been documented, it remains under-investigated whether this occurs via overlapping or distinct processes. Here, we established a sensitive bioluminescence-based assay to assess mechanisms underlying the secretion of pseudohyperphosphorylated and wild-type tau in cultured murine hippocampal neurons. We found that under basal conditions, both wild-type and mutant tau are secreted, with mutant tau being more robustly secreted. Pharmacological stimulation of neuronal activity led to a modest increase of wild-type and mutant tau secretion, whereas inhibition of activity had no effect. Interestingly, inhibition of heparin sulfate proteoglycan (HSPG) biosynthesis drastically decreased secretion of both wild-type and mutant tau without affecting cell viability. This shows that native and pathological tau share release mechanisms; both activity-dependent and non-activity-dependent secretion of tau is facilitated by HSPGs.
- 5 June 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1196007
Open AccessA luminescence-based reporter to study tau secretion reveals overlapping mechanisms for the release of healthy and pathological tau
In Alzheimer’s disease, tau pathology is thought to spread via a prion-like manner along connected neuronal networks. For this to occur, the usually cytosolic tau protein must be secreted via an unconventional mechanism prior to uptake into the connected neuron. While secretion of healthy and pathological tau has been documented, it remains under-investigated whether this occurs via overlapping or distinct processes. Here, we established a sensitive bioluminescence-based assay to assess mechanisms underlying the secretion of pseudohyperphosphorylated and wild-type tau in cultured murine hippocampal neurons. We found that under basal conditions, both wild-type and mutant tau are secreted, with mutant tau being more robustly secreted. Pharmacological stimulation of neuronal activity led to a modest increase of wild-type and mutant tau secretion, whereas inhibition of activity had no effect. Interestingly, inhibition of heparin sulfate proteoglycan (HSPG) biosynthesis drastically decreased secretion of both wild-type and mutant tau without affecting cell viability. This shows that native and pathological tau share release mechanisms; both activity-dependent and non-activity-dependent secretion of tau is facilitated by HSPGs.
- Open Access
Regional assessment of male murine bone exposes spatial heterogeneity in osteocyte lacunar volume associated with intracortical canals and regulation by VEGF
The porous bone cortex comprises an interconnected network of intracortical vascular canals and osteocyte lacunae, embedded within the bone mineral. Increases in cortical porosity reduce bone strength and increase fracture risk. To date, our understanding of mechanisms coupling the arrangements of the vascular: lacunar network in the bone cortex is poorly understood yet it could be key in establishing regulation of cortical porosity evident with age. Using synchrotron radiation-based computed tomography we develop automated tools to characterise the 3D spatial organisation and morphology of osteocyte lacunae, and the bone vasculature at the tibiofibular junction (TFJ), defining posterior, medial, lateral, and anterior regions in male C57BL/6 mice (n = 3). We also investigate the role of osteoblast-derived VEGF in regulating the 3D spatial arrangement by conditional disruption of VEGF in osteocalcin-expressing cells (OcnVEGFKO versus WT, n = 3). Regional lacunar phenotypes were assessed by 3D distance mapping of lacunar organisation surrounding the vascular compartments, including endosteal and periosteal surfaces, or intracortical canals. Surface-associated lacunae were indistinct in size across posterior, medial, lateral and anterior regions. However, lacunae associated with intracortical canals were significantly larger exclusively within the posterior region. In the absence of VEGF, the increased lacunar volume associated with posterior intracortical canals was lost. Our results suggest that the influence of intracortical canals on lacunar volumes is spatially regulated and sensitive to locally produced growth factors such as osteoblast-derived VEGF.
Open AccessRegional assessment of male murine bone exposes spatial heterogeneity in osteocyte lacunar volume associated with intracortical canals and regulation by VEGF
The porous bone cortex comprises an interconnected network of intracortical vascular canals and osteocyte lacunae, embedded within the bone mineral. Increases in cortical porosity reduce bone strength and increase fracture risk. To date, our understanding of mechanisms coupling the arrangements of the vascular: lacunar network in the bone cortex is poorly understood yet it could be key in establishing regulation of cortical porosity evident with age. Using synchrotron radiation-based computed tomography we develop automated tools to characterise the 3D spatial organisation and morphology of osteocyte lacunae, and the bone vasculature at the tibiofibular junction (TFJ), defining posterior, medial, lateral, and anterior regions in male C57BL/6 mice (n = 3). We also investigate the role of osteoblast-derived VEGF in regulating the 3D spatial arrangement by conditional disruption of VEGF in osteocalcin-expressing cells (OcnVEGFKO versus WT, n = 3). Regional lacunar phenotypes were assessed by 3D distance mapping of lacunar organisation surrounding the vascular compartments, including endosteal and periosteal surfaces, or intracortical canals. Surface-associated lacunae were indistinct in size across posterior, medial, lateral and anterior regions. However, lacunae associated with intracortical canals were significantly larger exclusively within the posterior region. In the absence of VEGF, the increased lacunar volume associated with posterior intracortical canals was lost. Our results suggest that the influence of intracortical canals on lacunar volumes is spatially regulated and sensitive to locally produced growth factors such as osteoblast-derived VEGF.
- Open Access
Functional effects of haemoglobin can be rescued by haptoglobin in an in vitro model of subarachnoid haemorrhage
During subarachnoid haemorrhage, a blood clot forms in the subarachnoid space releasing extracellular haemoglobin (Hb), which causes oxidative damage and cell death in surrounding tissues. High rates of disability and cognitive decline in SAH survivors is attributed to loss of neurons and functional connections during secondary brain injury. Haptoglobin sequesters Hb for clearance, but this scavenging system is overwhelmed after a haemorrhage. Whilst exogenous haptoglobin application can attenuate cytotoxicity of Hb and in vivo , and in vivo the functional effects of sub-lethal Hb concentrations on surviving neurons and whether cellular function can be protected with haptoglobin treatment remain unclear. Here we use cultured neurons to investigate neuronal health and function across a range of Hb concentrations to establish the thresholds for cellular damage and investigate synaptic function. Hb impairs ATP concentrations and cytoskeletal structure. At clinically relevant but sublethal Hb concentrations, synaptic AMPAR-driven currents are reduced, accompanied by a reduction in GluA1 subunit expression. Haptoglobin co-application can prevent these deficits by scavenging free Hb to reduce it to sub-threshold concentrations and does not need to be present at stoichiometric amounts to achieve efficacy. Haptoglobin itself does not impair measures of neuronal health and function at any concentration tested. Our data highlight a role for Hb in modifying synaptic function after SAH, which may link to impaired cognition or plasticity, and support the development of haptoglobin as a therapy for subarachnoid haemorrhage.
Open AccessFunctional effects of haemoglobin can be rescued by haptoglobin in an in vitro model of subarachnoid haemorrhage
During subarachnoid haemorrhage, a blood clot forms in the subarachnoid space releasing extracellular haemoglobin (Hb), which causes oxidative damage and cell death in surrounding tissues. High rates of disability and cognitive decline in SAH survivors is attributed to loss of neurons and functional connections during secondary brain injury. Haptoglobin sequesters Hb for clearance, but this scavenging system is overwhelmed after a haemorrhage. Whilst exogenous haptoglobin application can attenuate cytotoxicity of Hb and in vivo , and in vivo the functional effects of sub-lethal Hb concentrations on surviving neurons and whether cellular function can be protected with haptoglobin treatment remain unclear. Here we use cultured neurons to investigate neuronal health and function across a range of Hb concentrations to establish the thresholds for cellular damage and investigate synaptic function. Hb impairs ATP concentrations and cytoskeletal structure. At clinically relevant but sublethal Hb concentrations, synaptic AMPAR-driven currents are reduced, accompanied by a reduction in GluA1 subunit expression. Haptoglobin co-application can prevent these deficits by scavenging free Hb to reduce it to sub-threshold concentrations and does not need to be present at stoichiometric amounts to achieve efficacy. Haptoglobin itself does not impair measures of neuronal health and function at any concentration tested. Our data highlight a role for Hb in modifying synaptic function after SAH, which may link to impaired cognition or plasticity, and support the development of haptoglobin as a therapy for subarachnoid haemorrhage.
- Open Access
- 11 March 2021
- Published by SAGE Publications in Journal of Alzheimer's Disease Reports
- Vol. 5 (1) , 855-869
Molecular Investigation of the Unfolded Protein Response in Select Human Tauopathies
Background: Tauopathies are a group of neurodegenerative diseases associated with the accumulation of misfolded tau protein. The mechanisms underpinning tau-dependent proteinopathy remain to be elucidated. A protein quality control pathway within the endoplasmic reticulum, the unfolded protein response (UPR), has been suggested as a possible pathway modulating cellular responses in a range of neurodegenerative diseases, including those associated with misfolded cytosolic tau. Objective: In this study we investigated three different clinically defined tauopathies to establish whether these diseases are accompanied by the activation of UPR. Methods: We used PCR and western blotting to probe for the modulation of several reliable UPR markers in mRNA and proteins extracted from three distinct tauopathies: 20 brain samples from Alzheimer’s disease patients, 11 from Pick’s disease, and 10 from progressive supranuclear palsy. In each disease samples from these patients were compared with equal numbers of age-matched non-demented controls. Results: Our investigation showed that different markers of UPR are not changed at the late stage of any of the human tauopathies investigated. Interestingly, UPR signatures were often observed in non-demented controls. Conclusion: These data from late-stage human cortical tissue report an activation of UPR markers within the aged brain across all cohorts investigated and further support the emerging evidence that the accumulation of misfolded cytosolic tau does not drive a disease-associated activation of UPR.
- 11 March 2021
- Published by SAGE Publications in Journal of Alzheimer's Disease Reports
- Vol. 5 (1) , 855-869
Open AccessMolecular Investigation of the Unfolded Protein Response in Select Human Tauopathies
Background: Tauopathies are a group of neurodegenerative diseases associated with the accumulation of misfolded tau protein. The mechanisms underpinning tau-dependent proteinopathy remain to be elucidated. A protein quality control pathway within the endoplasmic reticulum, the unfolded protein response (UPR), has been suggested as a possible pathway modulating cellular responses in a range of neurodegenerative diseases, including those associated with misfolded cytosolic tau. Objective: In this study we investigated three different clinically defined tauopathies to establish whether these diseases are accompanied by the activation of UPR. Methods: We used PCR and western blotting to probe for the modulation of several reliable UPR markers in mRNA and proteins extracted from three distinct tauopathies: 20 brain samples from Alzheimer’s disease patients, 11 from Pick’s disease, and 10 from progressive supranuclear palsy. In each disease samples from these patients were compared with equal numbers of age-matched non-demented controls. Results: Our investigation showed that different markers of UPR are not changed at the late stage of any of the human tauopathies investigated. Interestingly, UPR signatures were often observed in non-demented controls. Conclusion: These data from late-stage human cortical tissue report an activation of UPR markers within the aged brain across all cohorts investigated and further support the emerging evidence that the accumulation of misfolded cytosolic tau does not drive a disease-associated activation of UPR.
- Open Access
- 1 September 2020
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 48 (17) , 9822-9839
A 5′ UTR GGN repeat controls localisation and translation of a potassium leak channel mRNA through G-quadruplex formation
RNA G-quadruplexes (G4s) are secondary structures proposed to function as regulators of post-transcriptional mRNA localisation and translation. G4s within some neuronal mRNAs are known to control distal localisation and local translation, contributing to distinct local proteomes that facilitate the synaptic remodelling attributed to normal cellular function. In this study, we characterise the G4 formation of a (GGN)13 repeat found within the 5′ UTR of the potassium 2-pore domain leak channel Task3 mRNA. Biophysical analyses show that this (GGN)13 repeat forms a parallel G4 in vitro exhibiting the stereotypical potassium specificity of G4s, remaining thermostable under physiological ionic conditions. Through mouse brain tissue G4-RNA immunoprecipitation, we further confirm that Task3 mRNA forms a G4 structure in vivo. The G4 is inhibitory to translation of Task3 in vitro and is overcome through activity of a G4-specific helicase DHX36, increasing K+ leak currents and membrane hyperpolarisation in HEK293 cells. Further, we observe that this G4 is fundamental to ensuring delivery of Task3 mRNA to distal primary cortical neurites. It has been shown that aberrant Task3 expression correlates with neuronal dysfunction, we therefore posit that this G4 is important in regulated local expression of Task3 leak channels that maintain K+ leak within neurons.
- 1 September 2020
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 48 (17) , 9822-9839
Open AccessA 5′ UTR GGN repeat controls localisation and translation of a potassium leak channel mRNA through G-quadruplex formation
RNA G-quadruplexes (G4s) are secondary structures proposed to function as regulators of post-transcriptional mRNA localisation and translation. G4s within some neuronal mRNAs are known to control distal localisation and local translation, contributing to distinct local proteomes that facilitate the synaptic remodelling attributed to normal cellular function. In this study, we characterise the G4 formation of a (GGN)13 repeat found within the 5′ UTR of the potassium 2-pore domain leak channel Task3 mRNA. Biophysical analyses show that this (GGN)13 repeat forms a parallel G4 in vitro exhibiting the stereotypical potassium specificity of G4s, remaining thermostable under physiological ionic conditions. Through mouse brain tissue G4-RNA immunoprecipitation, we further confirm that Task3 mRNA forms a G4 structure in vivo. The G4 is inhibitory to translation of Task3 in vitro and is overcome through activity of a G4-specific helicase DHX36, increasing K+ leak currents and membrane hyperpolarisation in HEK293 cells. Further, we observe that this G4 is fundamental to ensuring delivery of Task3 mRNA to distal primary cortical neurites. It has been shown that aberrant Task3 expression correlates with neuronal dysfunction, we therefore posit that this G4 is important in regulated local expression of Task3 leak channels that maintain K+ leak within neurons.